Eli Lilly released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without insurance coverage for the blockbuster injection, such as those with Medicare.
The company is offering those vials through its direct-to-consumer website, LillyDirect, which started offering lower doses of the drug in vials in August.
